Improved health-related quality of life during peptide receptor radionuclide therapy in patients with neuroendocrine tumours.

Edfeldt, Katarina et al.·Journal of neuroendocrinology·2023·
RPEP-068592023RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Not classified
Evidence
Not graded
Sample
Not reported

What This Study Found

HRQoL improved in global quality of life, role, social, and emotional functioning.

Key Numbers

How They Did This

The study involved 204 NET patients who completed HRQoL questionnaires before and after up to four cycles of PRRT, with results compared to a reference population.

Why This Research Matters

Improving HRQoL is crucial for cancer patients, as it directly impacts their overall well-being and treatment satisfaction. These findings can guide personalized care approaches.

What This Study Doesn't Tell Us

The study may not account for all variables affecting HRQoL and was limited to a specific patient population.

Trust & Context

Original Title:
Improved health-related quality of life during peptide receptor radionuclide therapy in patients with neuroendocrine tumours.
Published In:
Journal of neuroendocrinology, 35(10), e13342 (2023)
Database ID:
RPEP-06859

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Read More on RethinkPeptides

Related articles coming soon.

Cite This Study

RPEP-06859·https://rethinkpeptides.com/research/RPEP-06859

APA

Edfeldt, Katarina; Hellman, Per; Granberg, Dan; Lagergren, Pernilla; Thiis-Evensen, Espen; Sundin, Anders; Andersson, Camilla. (2023). Improved health-related quality of life during peptide receptor radionuclide therapy in patients with neuroendocrine tumours.. Journal of neuroendocrinology, 35(10), e13342. https://doi.org/10.1111/jne.13342

MLA

Edfeldt, Katarina, et al. "Improved health-related quality of life during peptide receptor radionuclide therapy in patients with neuroendocrine tumours.." Journal of neuroendocrinology, 2023. https://doi.org/10.1111/jne.13342

RethinkPeptides

RethinkPeptides Research Database. "Improved health-related quality of life during peptide recep..." RPEP-06859. Retrieved from https://rethinkpeptides.com/research/edfeldt-2023-improved-healthrelated-quality-of

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.